Nurocutaneous Syndrome:a multicenter prospective cohort study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047816

Enrollment

Unknown

Registered

2021-06-27

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurocutaneous syndrome

Interventions

Case group:none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: After approval from the Institutional Ethical Committee, subjects between ages of 0 and 28 days, who fulfilled the inclusion criteria, were enrolled, after obtaining an informed consent from the parents, during the period from July, 2021 to February, 2023.

Exclusion criteria

Exclusion criteria: Those who failed follow-up.

Design outcomes

Primary

Measure	Time frame
neurological examinations;Screening of blood and urine herediatary metabolic diseases;	—

Countries

China

Contacts

Public ContactFeng Zhichun

The Seventh Medical Center of PLA General Hospital

Zhifengzc@126.com+86 10 66721786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026